Rhythm Pharmaceuticals, Inc. RYTM Other income, net (Note 6)
Other income, net (Note 6) at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s other income, net (note 6)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported other income, net (note 6) of -$1.7M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s other income, net (note 6) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s other income, net (note 6) decreased by 164.6% year-over-year, from -$644K to -$1.7M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s other income, net (note 6)?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s other income, net (note 6) has grown at a -66.5% compound annual growth rate (CAGR), from $100M to $1.26M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.